Insilico Medicine

About Insilico Medicine

Insilico Medicine is a clinical stage biotech company powered by generative AI. We connect biology, chemistry, and clinical trials analysis using next-generation AI systems. Our AI platforms utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.